Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fabrizio Ciaralli"'
Autor:
Matteo Tamburlani, Tiziana Trequattrini, Simona Rossi, Maria Cristina Zappa, Rossana Cuscito, Leonardo Papi, Arianna Colelli, Giovanni Galeoto, Ilaria Ruotolo, Fabrizio Ciaralli, Annamaria Servadio
Publikováno v:
Journal of Biomedical Practitioners, Vol 8, Iss 1 (2024)
INTRODUZIONE Il sonno è un processo fisiologico caratterizzato da una riduzione dello stato di coscienza e ha un impatto importante sulla qualità della vita (QoL). I disturbi del sonno sono comuni nelle persone affette da Long Covid, complessa c
Externí odkaz:
https://doaj.org/article/20e6045889c64234bf3417180cadf1d6
Autor:
Fabrizio, Ciaralli, Elisabetta, Fusconi, Giulia, Cairella, Massimo, Trinito, Giuseppe, De Angelis, Italo, D'Ascanio, Igina, Nardelli, Concetto, Saffioti, Flori, Degrassi
Publikováno v:
Igiene e sanita pubblica. 75(6)
The avoidable mortality (ME)represents the share of deaths that occurs at an early age (0-74 aa) for causes that cannot be faced by means of public health or health care measures. The work develops a strategic intervention plan aimed at the reduction
Publikováno v:
Igiene e sanita pubblica. 74(6)
Pharmaceutical expenditure is a cost item that is monitored continuously, to verify the appropriateness of prescriptions, the good use of available resources and to contain costs. However, socioeconomic differences in the population affect health con
Autor:
Fabrizio, Ciaralli, Italo, D'Ascanio, Concetto, Saffioti, Giorgio, Spunticchia, Carla, Perria, Gianni, Vicario, Maurizio, Zega, Augusto, Panà
Publikováno v:
Igiene e sanita pubblica. 68(2)
Clinical governance of healthcare and community services by healthcare organizations requires the use of validated tools for identifying the specific healthcare needs of the local population. The population served by a local health organization may b
Autor:
Fabrizio, Ciaralli, Francesco, Summaria, Marina, Mustilli, Loredana, Vasselli, Antonio, D'Urso, Flori, Degrassi
Publikováno v:
Igiene e sanita pubblica. 66(4)
In chronic diseases the adherence and persistence to therapeutic treatments are often lower than guidelines said. This leads to a worse therapeutic effect of the treatments and to a misuse in healthcare costs. Our study evaluates the impact of a phar
Autor:
Italo, D'Ascanio, Fabrizio, Ciaralli, Carla, Perria, Giorgio, Spunticchia, Gianni, Vicario, Maurizio, Zega, Piero, Borgia, Antonio, D'Urso, Gabriella, Guasticchi, Flori, Degrassi
Publikováno v:
Igiene e sanita pubblica. 66(2)
A set of indicators for assessing healthcare needs and evaluating healthcare services are needed. This paper presents a set of indicators for evaluating healthcare districts, defined by a local health authority in the city of Rome. The set of indicat
[Feasibility of behavioural interventions for tobacco smoking cessation in routine general practice]
Autor:
Fabrizio, Ciaralli, Sergio, Rovetta, Valentina, Rebella, Piero, Borgia, Nunzio, Molino, Francesco, Chini, Piergiorgio, Zuccaro, Antonio, D'Urso, Augusto, Panà
Publikováno v:
Igiene e sanita pubblica. 62(6)
The aims of this study were: 1) to evaluate a training course on smoking cessation techniques offered to general practitioners of the RMB Local Health Unit (Rome, Italy) 2) to evaluate the feasibility of delivering brief counseling interventions duri
Autor:
Fabrizio, Ciaralli, Matteo, Ciavarella, Valentina, Rebella, Luca, Fersini, Giuliana, Ausili, Lia, Delli Colli, Sergio, Rovetta
Publikováno v:
Igiene e sanita pubblica. 60(5)
Tobacco smoke represents the main cause of preventable morbidity and mortality in Western countries: in Italy, approximately 85.000 persons die each year because of smoke-related illnesses. Starting from the objectives defined by the 2001/2003 Nation
Autor:
Antonella Sette, Francesco Summaria, Marina Mustilli, Fabrizio Ciaralli, Loredana Vasselli, Chiara Lanzillo
Publikováno v:
Medical Archives. 67:314
Background: The compliance to statins in secondary prevention is very low, increasing health-care costs principally for rehospitalization. Objectives: To evaluate the cost of lack of persistence to statin therapy together with identification and cost